Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Genetic Architecture Drives Differences in RNA Editing Rates between Alzheimer Disease Cases and Controls in Diverse Populations
Aging, Dementia, Cognitive, and Behavioral Neurology
P6 - Poster Session 6 (12:00 PM-1:00 PM)
10-003

We have shown that RNA editing, the post-transcriptional modification of RNA bases, is altered between AD cases and controls in both AA and NHW (Gardner, 2019). However, it is unknown whether DNA variants that influence the rates of RNA editing, referred as edQTLs (similar to eQTLs), are contributing to these differences in both populations. 

To determine whether RNA editing quantitative trait loci (edQTLs) explain RNA editing differences between Alzheimer disease (AD) cases and controls in African-American (AA) and Non-Hispanic White (NHW) populations.

We performed edQTL analysis using RNAseq from peripheral blood of 216 AD cases (105 AA, 111 NHW) and 212 cognitively intact controls (105 AA, 107 NHW), all over age 65. FastQTL was used to map edQTLs using genotyping data from the Infinium GSA with editing rates calculated with REDItools, adjusting for covariates.  Associations with an FDR corrected p-value less than 1% were considered significant.

We identified 14,022 (AA) and 9,174 (NHW) edQTLs. Of these, 104 in AA and 46 in NHW were edQTLs for sites differentially edited between AD cases and controls. Among the edQTLs associated with differentially edited sites, 31 were in linkage disequilibrium (r2>=0.5) with an AD-associated region defined by the European-ancestry genome-wide association study from the International Genomics of Alzheimer’s Project (Kunkle, 2019). These edQTLs were strongly enriched amongst NHW (23 NHW only, 8 both, 0 AA only) and included the SORL1, SLC24A4, SPI1, and HLA-DRB1 gene loci.

Our data support our hypothesis that edQTLs contribute to RNA editing differences between AD cases and controls in both AA and NHW and thus could be a mechanism for the functional effect of AD risk variants. However, edQTLs in regions associated with AD in European ancestry did not generalize across ancestries, underscoring the crucial need for genetic studies in multi-ethnic populations to understand mechanisms of AD risk.

Authors/Disclosures
Olivia Gardner, MD, PhD (Massachusetts General Hospital)
PRESENTER
No disclosure on file
Lily Wang No disclosure on file
Derek Van Booven No disclosure on file
Patrice Whitehead Patrice Whitehead has nothing to disclose.
Kara Hamilton-Nelson Kara Hamilton-Nelson has nothing to disclose.
Larry D. Adams Larry D. Adams has nothing to disclose.
Takiyah Starks No disclosure on file
Natalia Hofmann No disclosure on file
Jeffery M. Vance, MD, PhD (University of Miami) Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Michael L. Cuccaro Michael L. Cuccaro has nothing to disclose.
Eden R. Martin No disclosure on file
Goldie S. Byrd Goldie S. Byrd has nothing to disclose.
Jonathan Haines, MD (Vanderbilt University) No disclosure on file
William Bush No disclosure on file
Gary W. Beecham, PhD (University of Miami, Hussman Institute for Human Genomics) The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Margaret A. Pericak-Vance, PhD (University of Miami Miller School of Medicine) Dr. Pericak-Vance has nothing to disclose.
Anthony J. Griswold, PhD (University of Miami) Dr. Griswold has received research support from National Institutes of Health.